InteKrin Therapeutics, Inc.

Website Links

Description

Dennis M. Lanfear Chairman of the Board and Founder Mr. Lanfear, InteKrin’s founder, became Chairman of the Board in 2010. Under Mr. Lanfear’s five year leadership as President and CEO, the company was taken from inception through a successful End-Of-Phase-2 meeting with the FDA and into Phase 3 with a major therapeutic area lead product of high market potential. Denny is a thirteen year veteran of Amgen, Incorporated where he was a Corporate Officer and Vice-President with broad operational, product development and marketing responsibility. His tenure began in 1986 as founder of the Process Development Department. Under his ten-year leadership this group became the preeminent PD organization in BioPharma and a key strategic advantage for the company, as it remains today. As Vice President Process Development and Operations Systems, he directed the business process integration of over twenty-five hundred Operations and Quality staff world-wide. While at Amgen he also had senior leadership roles in several product development programs including those for growth factors, somatotrophins and neurotrophins, directing efforts from preclinical to Phase III. He reviewed and wrote sections of more that 20 INDs and several BLAs. He managed several corporate partner relationships including that with SKB from 1986 to 1990. He also managed and had direct budgetary responsibility for the $135M development partnership with Regeneron Pharmaceuticals from 1991 to 1999. In 1997 he was named Vice President, Market Development, where he defined long term competitive and reimbursement strategies for Epogen

Products & services

Similar companies nearby